Cargando…

Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy

Vaccination is defined as the stimulation and development of the adaptive immune system by administering specific antigens. Vaccines' efficacy, in inducing immunity, varies in different societies due to economic, social, and biological conditions. One of the influential biological factors is gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemifard, Nesa, Dehkohneh, Abolfazl, Baradaran Ghavami, Shaghayegh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606607/
https://www.ncbi.nlm.nih.gov/pubmed/36313997
http://dx.doi.org/10.3389/fmed.2022.940454
_version_ 1784818333617487872
author Kazemifard, Nesa
Dehkohneh, Abolfazl
Baradaran Ghavami, Shaghayegh
author_facet Kazemifard, Nesa
Dehkohneh, Abolfazl
Baradaran Ghavami, Shaghayegh
author_sort Kazemifard, Nesa
collection PubMed
description Vaccination is defined as the stimulation and development of the adaptive immune system by administering specific antigens. Vaccines' efficacy, in inducing immunity, varies in different societies due to economic, social, and biological conditions. One of the influential biological factors is gut microbiota. Cross-talks between gut bacteria and the host immune system are initiated at birth during microbial colonization and directly control the immune responses and protection against pathogen colonization. Imbalances in the gut microbiota composition, termed dysbiosis, can trigger several immune disorders through the activity of the adaptive immune system and impair the adequate response to the vaccination. The bacteria used in probiotics are often members of the gut microbiota, which have health benefits for the host. Probiotics are generally consumed as a component of fermented foods, affect both innate and acquired immune systems, and decrease infections. This review aimed to discuss the gut microbiota's role in regulating immune responses to vaccination and how probiotics can help induce immune responses against pathogens. Finally, probiotic-based oral vaccines and their efficacy have been discussed.
format Online
Article
Text
id pubmed-9606607
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96066072022-10-28 Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy Kazemifard, Nesa Dehkohneh, Abolfazl Baradaran Ghavami, Shaghayegh Front Med (Lausanne) Medicine Vaccination is defined as the stimulation and development of the adaptive immune system by administering specific antigens. Vaccines' efficacy, in inducing immunity, varies in different societies due to economic, social, and biological conditions. One of the influential biological factors is gut microbiota. Cross-talks between gut bacteria and the host immune system are initiated at birth during microbial colonization and directly control the immune responses and protection against pathogen colonization. Imbalances in the gut microbiota composition, termed dysbiosis, can trigger several immune disorders through the activity of the adaptive immune system and impair the adequate response to the vaccination. The bacteria used in probiotics are often members of the gut microbiota, which have health benefits for the host. Probiotics are generally consumed as a component of fermented foods, affect both innate and acquired immune systems, and decrease infections. This review aimed to discuss the gut microbiota's role in regulating immune responses to vaccination and how probiotics can help induce immune responses against pathogens. Finally, probiotic-based oral vaccines and their efficacy have been discussed. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9606607/ /pubmed/36313997 http://dx.doi.org/10.3389/fmed.2022.940454 Text en Copyright © 2022 Kazemifard, Dehkohneh and Baradaran Ghavami. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Kazemifard, Nesa
Dehkohneh, Abolfazl
Baradaran Ghavami, Shaghayegh
Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
title Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
title_full Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
title_fullStr Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
title_full_unstemmed Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
title_short Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
title_sort probiotics and probiotic-based vaccines: a novel approach for improving vaccine efficacy
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606607/
https://www.ncbi.nlm.nih.gov/pubmed/36313997
http://dx.doi.org/10.3389/fmed.2022.940454
work_keys_str_mv AT kazemifardnesa probioticsandprobioticbasedvaccinesanovelapproachforimprovingvaccineefficacy
AT dehkohnehabolfazl probioticsandprobioticbasedvaccinesanovelapproachforimprovingvaccineefficacy
AT baradaranghavamishaghayegh probioticsandprobioticbasedvaccinesanovelapproachforimprovingvaccineefficacy